Impressed by the commitment to our patients of our KidneyCancerProgram faculty and UTSW Simmons Cancer Center medical providers and staff.

Congratulations to Haitao Xu KidneyCancerProgram UTSW Internal Medicine UT Southwestern Medical Center getting the resident Seldin Award for his research on pancreatic tropism of #RCC with Payal Kapur UTSW Hematology & Oncology

Agree

Thank you Brad Cutrell, MD, FIDSA UT Southwestern Medical Center for organizing a terrific conference! Hope it went well!

Any patient w #kidneycancer is welcome to attend our KidneyCancerProgram education symposium in Dallas Sat 4/27! Come learn from my colleagues James Brugarolas Hans Hammers Payal Kapur & many more #kidneycancer experts.
Register here: bit.ly/3VyG4rt
Kidney Cancer KCCure KidneyCAN

📢Event announcement! The KCP will be hosting an educational event for kidney cancer patients of both Parkland and UTSW on April 27th, from 9AM to 3PM. Check out our program below, and RSVP here: bit.ly/3VyG4rt

Today was the first meeting of 2024 for our VIP-C delegates, a collaborative effort aimed at uniting students, physicians, and faculty across every step of their career. Interested in VIP-C? Learn more about the program: utsouthwestern.edu/education/prog…

We appreciate you 😀

Looking forward to this

Thank you Joey's Wings Foundation for your support, which laid the ground for this work, and your continued advocacy on behalf of #tRCC patients!

Congratulations to our Board Chair, Dr. Michael Jewett, on being invested to the Order of Canada by Her Excellency the Right Honourable Mary Simon, Governor General of Canada today in Ottawa. (1/2)

Congratulations to Gopi, Payal Kapur and all authors on developing tRCC model UTSW Simmons Cancer Center and thanks to all the #kidneycancer KidneyCancerProgram patients that contributed as well as CPRIT, Joey's Wings Foundation, Plano Pacers and Dallas DASH that made this possible. jci.org/articles/view/…

The UTSW Simmons Cancer Center UTSW Radiation Oncology UT Southwestern Urology UTSW Hematology & Oncology GU oncology representation — an honor to work & care for patients alongside these wonderful people ASCO #GU24 Hans Hammers James Brugarolas Charles Jiang MD, MPH Kris Gaston, MD, FACS Solomon Woldu Suzanne Cole, MD #KevinCourtney

Congratulations Qing Zhang!

With side effect profile without cardiotoxicity, wound healing problems and autoimmunity, and good tolerability, a great addition for #RCC patients beyond those with VHL VHL Alliance KidneyCancerProgram

JUST IN: U.S. FDA approved belzutifan (HIF2 inhibitor) in advanced renal cell carcinoma (RCC) following PD1 and VEGF inhibitors!

A great day for the field and a new option for our Kidney Cancer patients!!!!

Via ASCO #FDAAlerts OncoAlert

Study presented at ESMO - Eur. Oncology #ESMO3 by

Belzutifan developed by #UTSW spinoff Peloton approved for sporadic #RCC culminating 25 year KidneyCancerProgram journey starting from HIF2a gene discovery with National Cancer Institute SPORE funding bit.ly/BelzutifanAppr… based on #litespark005 led by Toni Choueiri, MD presented at ESMO - Eur. Oncology Laurence Albiges approved by

👨‍⚕️ Dr. Hans Hammers outlines rationale for targeting PTPN2 in RCC—anticipating dual impact on cancer cells and immunomodulation. Excitement builds for upcoming clinical trial results with RCC cohort and KCRC involvement! 🚀🔍 #RCCResearch #KCRC